AITX Pushes Cash Breakeven to Jan 2027, Expands Cost Cuts
AITX sits 20% above its 52-week low of $0.001 on elevated volume (3.6× avg).
Summary
AITX now expects monthly operating cash breakeven in January 2027, a month later than the December 2026 target it set with the August cost-reduction plan. The delay is offset by deeper cuts: about $345K a month in January and $350K+ from February, versus the $200K a month outlined in August. The definition is narrow — it excludes debt service and device build costs, so the company still needs outside financing and dilution risk stays until all-in breakeven, which management targets for Q2 2027. The plan leans on roughly 2.7% monthly revenue growth and a narrowed product lineup (SARA, RAIA, ROAMEO, with others paused), an aggressive assumption against the prior 12 months. This follows the September 8-K showing a 14% cut in selected operating expenses and the September 3 disclosure that the August positive cash flow target was missed.
At the time of this announcement, AITX was trading at $0.00 on OTC in the Technology sector, with a market capitalization of approximately $796.1K. The 52-week trading range was $0.00 to $0.12. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.